Award winning executive search to the private, and investor backed health, care, and life sciences sectors

Health Tech Round Table: A discussion around the challenges and opportunities within HealthTech domestically and globally

Trusted executive search partner to the investment community delivering outstanding leaders for the healthcare and life sciences sectors

Mandates delivered to date

0 %

Delivery rate of all retained mandates

0 %

C-suite appointments are women

0 +

Sub-sectors in healthcare and life sciences supported

Healthcare news, data and analysis
Via Investors in Healthcare

MoonLake Immunotherapeutics is a Switzerland-based clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational nanobody for the treatment of inflammatory diseases. Founded in 2021, MoonLake builds on robust […]

IIH interview: Matthias Bodenstedt discusses MoonLake’s capital raising journey, the appeal of SLK and plans for the future

June 13, 2025

Analysis Manufacturing – Specialty Pharma News Pharma Matthias Bodenstedt

Mehiläinen, Finland’s largest social care and healthcare provider, has priced an offering of €350m (US$404m) senior secured floating rate notes due 2032 with a coupon of three-month Euribor, subject to […]

Finland: Mehiläinen prices notes to complete acquisitions of Regina Maria and MediGroup

June 13, 2025

Debt Healthcare Hospitals and Clinics News Finland

The UK charity International Finance Facility for Immunisation (IFFIm) – rated Aa1/AA/AA- (Moody’s/S&P/Fitch) – has crossed the US$10bn mark in vaccine bond issuance, following the settlement of its latest £300m […]

UK: IFFIm £300m bond takes total vaccine bond issuance over US$10bn

June 13, 2025

Debt News Barclays International Finance Facility for Immunisation (IFFIm) NatWest Markets

KKR and Stonepeak have reached agreement with Assura on the terms of a recommended best and final increased cash offer for Assura of 50.42 pence per share. In addition, Assura […]

UK: Assura reaches agreement with KKR and Stonepeak on best and final cash offer

June 12, 2025

Buy Out Healthcare Hospitals and Clinics M&A News

Clariane, the France-listed care operator, has sold its Petits-fils network to Crédit Agricole Santé & Territoires for an enterprise value of €345m (US$400m). Founded in 2007, Petits-fils – the leading […]

France: Clariane completes financial structure strengthening plan with disposal of Petits-fils

June 12, 2025

Buy Out Homecare M&A Social Care Clariane

US-headquartered Heitman, a global real estate investment management firm, has announced an allocation from Hesta, one of Australia’s largest superannuation funds, to invest in European alternative property types, including self-storage, […]

Europe: Hesta to invest in European alternative property types with Heitman

June 12, 2025

News Real Estate Caleb Mercer Europe Heitman

Press reports, quoting a Bloomberg article, point to Malaysia’s Employees Provident Fund (EPF) appointing Knight Frank to offer for sale a UK portfolio of 12 private hospitals for around £1.4bn.

UK: Press reports: Knight Frank appointed by EPF to sell UK private hospital portfolio

June 11, 2025

Healthcare Hospitals and Clinics M&A M&A Deals News

Demant, the Denmark-based global hearing healthcare group, is to acquire Kind Group, Germany’s leading family-owned company in the fields of hearing care and hearing aid technology, for €700m (US$800m) on […]

Germany: Demant expanding hearing care footprint with acquisition of Kind Group

June 11, 2025

Buy Out Healthcare Hospitals and Clinics Life Sciences M&A

SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, has closed a US$135m Series B co-led by new investors EQT Life Sciences and Sanofi […]

Spain: SpliceBio closes US$135m Series B financing round

June 11, 2025

News Pharma Venture Asabys Partners Carole Nuechterlein

Faes Farma, a Spain-based pharmaceutical company listed on the Spanish stock exchange, is acquiring SIFI, an Italy-based international ophthalmic company, from shareholders – the founding families and 21 Invest, which […]

Italy: Faes Farma acquires SIFI to expand ophthalmic franchise

June 11, 2025

Buy Out Debt Healthcare M&A News

Nordic Capital is making an undisclosed investment in Minerva, a Denmark-based CRO and CDMO specialising in the development of targeted radioligand therapies. The investment, made in close partnership with the […]

Denmark: Nordic Capital partners with Minerva Imaging to support growth journey in radiopharmaceutical space

June 10, 2025

M&A News Pharma Services – CRO/CMO/CDMO Venture

Spectris, a UK-listed supplier of precision instrumentation and controls, has received a possible cash offer for its shares from US-based PE firm, Advent International, of £37.63 per Spectris share, valuing […]

UK: Spectris confirms proposal from Advent International

June 10, 2025

Buy Out M&A News Pharma Public Equity

Nasdaq-listed Merus, an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates, has priced an underwritten public offering of 5,263,158 common shares at US$57.00 per share to raise US$300m. […]

The Netherlands: Merus raises US$300m from underwritten public offering

June 10, 2025

Manufacturing – Specialty Pharma News Pharma Public Equity BofA Securities

US-based PE firm, Advent, is investing US$$175m via primary and secondary for a significant minority stake in Dublin headquartered Felix Pharmaceuticals, a developer and manufacturer of off-patent medicines for companion […]

India: Advent partners with Felix to build generic animal health leader

June 10, 2025

Animal Health Manufacturing – Generics News Pharma Venture

Global beauty player, L’Oréal Groupe to acquire a majority stake in the British skincare brand Medik8. As part of the transaction, Inflexion, a European mid-market private equity firm, will remain a […]

UK: L’Oréal Groupe to acquire a majority stake in Medik8

June 9, 2025

Cosmetic & Aesthetics Healthcare M&A News Cyril Chapuy

US-based alternative investment firm, HIG Capital, has completed the acquisition of ITH Group, a UK provider of aseptic pharmaceutical compounding services, in partnership with its founders Adam Bloom and Karen […]

UK: HIG Capital completes acquisition of ITH Group

June 9, 2025

Buy Out Healthcare Life Sciences M&A Medtech – Medical Devices and Implants

UK-focused social infrastructure investment manager Newcore Capital has been appointed general partner to The Newcore Swansea Social Infrastructure Partnership (NSSIP), a new the £50m-plus (US$68m) local impact fund launched in collaboration with […]

UK: Newcore Capital and Swansea Council launch £51m local impact fund

June 9, 2025

News Social Care City and County of Swansea Pension Fund Hugo Llewelyn Jeff Dong

Hakim Group, the UK’s largest family of independent opticians and audiologists, bring global alternative asset manager, ICG, on board as an additional investment partner is to accelerate its expansion. Existing […]

UK: Hakim Group to accelerate expansion plans with investment from ICG

June 9, 2025

Buy Out Healthcare M&A News Ophthalmology

Caring Times, a UK publication for care managers, owners and directors, has named US-based Omega Healthcare Investors as the acquirer of the majority of the remaining care homes in the […]

UK: Omega Healthcare Investors revealed as acquirer of Four Seasons’ remaining care homes

June 9, 2025

Care Homes M&A M&A Deals News Real Estate

Joined-up care leads to better outcomes and there is a growing focus on community-based solutions as a pathway to create better services based on local need. This presents a real […]

IIH Interview: LDC’s Aziz Ul-Haq and Aylesh Patel discuss how healthcare businesses can unlock value through strategic partnerships with private equity

June 6, 2025

Analysis Consumer Healthcare Diagnostics Digital Health/Healthtech Healthcare

Miura Partners, a PE firm with offices in Barcelona and Madrid, has joined forces with the founders of the mental healthcare centres Centro Psicosanitario Galiani (Seville) and Orientak (Madrid), José Antonio Galiani and Eva […]

Spain: Miura invests in mental healthcare and emotional wellbeing in Spain

June 6, 2025

Healthcare M&A Mental Health News Centro Psicosanitario Galiani

Juvenescence, a clinical stage AI-enabled biotech company, has acquired Ro5 Inc, a proprietary AI drug discovery company. “The addition of Ro5’s AI platform significantly enhances our drug discovery capabilities, accelerating […]

UK: Juvenescence acquires Ro5 to boost R&D capabilities and drive pipeline

June 6, 2025

Buy Out M&A News Pharma Juvenescence

Healthcare Holding Schweiz, a Switzerland-based healthcare buy, build & technology platform, has completed the acquisition of Ino Medical Solutions in Rapperswil-Jona, a specialist provider of sterile containers and medical instruments […]

Switzerland: Healthcare Holding Schweiz completes acquisition of Ino Medical Solutions

June 5, 2025

Buy Out Life Sciences M&A Medtech – Hospital Equipment News

Belgium-based healthcare REIT, Aedifica, has invested €47m (US$53.5m) in the acquisition and development of nine care properties in Finland. “With these investments, we are delivering on our commitment to reinvest […]

Finland: Aedifica invests €47m in acquisition and development of care properties in Finland

June 4, 2025

Care Homes Complex Behavioural Care M&A M&A Deals News

Impilo, a Nordic investment company focused solely on investments in lower-mid-market Nordic healthcare companies, has announced the final closing of Fund II, its first euro-denominated, closed-end fund, at the hard […]

Sweden: Impilo closes Fund II at hard cap of €700m

June 4, 2025

Buy Out Healthcare Life Sciences News Pharma

Our Sectors

We are experts at what we do

Healthcare

Social Care

Biopharmaceuticals

Medical Technologies

Enabling Services

01 Our People

A dedicated team of executive search experts, delivering for you

The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.

Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.

Our Team

Meet the Team

Adam Carter

Meet the Team

Luke Osborne

Meet the Team

Abigail Badà

Meet the Team

Sam Leighton-Smith BA Hons

02 Expertise

Unearthing rare talent, that drive successful exits

Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.

Expertise

Board

Expertise

Executive Leadership

Expertise

Finance & Commercial

Expertise

People & Culture

03 Our Approach

Tailoring our offering,
to provide a bespoke service

Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.

Our Approach

A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors

What our clients say

“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”

Outcomes First Group – Chair

“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”

Hengrui Therapeutics – VP, Head Biological Drug Discovery

“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”

The Professional Footballers Association (PFA) – Chief Executive Officer

“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”

Priory Group – Chief Executive Officer

“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”

Priory – Independent Non-Executive Director

“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”

AniCura – Group Chief Operating Officer

“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building. Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”

Renaiss Health – Chief Executive Officer

“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”

One Nucleus – Director

“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”

Melrose Education – Chair & CEO

“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”

Schoen Clinic – Member of Group Executive